New heart test could spot hidden dangers in long QT patients
NCT ID NCT07270211
First seen Jan 02, 2026 · Last updated May 18, 2026 · Updated 31 times
Summary
This study compares a new heart test called magnetocardiography (MCG) to the standard ECG in 100 adults with Long QT syndrome and atrial fibrillation. The goal is to see if MCG can more accurately predict who will have complications during treatment with a heart medication. Participants will have both tests, and researchers will track how well the medication is tolerated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Contact
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.